Purple Biotech to Attend HC Wainwright’s 26th Annual Global Investment Conference Page 1

REHOVOT, Israel, Aug. 30, 2024 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing breakthrough therapies to overcome tumor immune evasion and drug resistance, today announced that its management will participate in HC Wainwright’s 26th Annual Global Investment Conference in the form of a Fireside Chat presentation (virtual) and one-on-one discussions.

The conference will be held September 9-11, 2024 and the virtual Fireside Chat will be available on-demand beginning Monday, September 9 at 7:00 a.m. ET in the Investor section of Purple Biotech’s website at www.purple-biotech.com for 30 days. Institutional investors interested in listening to Purple Biotech’s Fireside Chat can click the following link (www.hcwevents.com/annualconference) to register for the conference.